Timothy Simplot, MD
Otolaryngology · West Des Moines, IANPI 1275591273
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,995 of the $6,019 with a category attached, or 83.0%. It is spread thinly across 34 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,955 and has fallen 61.7% since, to $748 in 2025. Among otolaryngology clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $27.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Aerin Medical Inc.$727
- Regeneron Healthcare Solutions, Inc.$639
- Acclarent, Inc$606
- Sanofi$412
- Optinose US, Inc.$378
- plus $2K from 28 others
What the payments were for
- Travel & lodging$1,02017%
- Food & beverage$4,99583%
- Gifts$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 6 | $1,089 |
| Aerin Medical Inc. | 26 | $727 |
| Regeneron Healthcare Solutions, Inc. | 29 | $639 |
| Acclarent, Inc | 21 | $606 |
| Sanofi | 24 | $412 |
| Optinose US, Inc. | 25 | $378 |
| Intersect ENT, Inc. | 12 | $351 |
| KARL Storz Endoscopy-america | 8 | $335 |
| Stryker | 7 | $268 |
| Itamar Medical Inc | 4 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $134 |
| Smith+Nephew | 7 | $128 |
| Phathom Pharmaceuticals, Inc. | 5 | $88 |
| Alk-abello, Inc | 5 | $75 |
| Organogenesis Inc. | 2 | $66 |
| Kaleo, Inc. | 4 | $65 |
| Medtronic | 3 | $60 |
| Amgen | 3 | $57 |
| Integra Lifesciences Corporation | 1 | $50 |
| Johnson & Johnson(2 entities) | 2 | $47 |
| Hologic Sales And Service, LLC | 2 | $46 |
| Neurent Medical Limited | 1 | $28 |
| Preceptis Medical, Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Merz North America, Inc. | 1 | $20 |
| Cochlear Americas | 1 | $20 |
| AstraZeneca | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 |
| Xoran Technologies LLC | 1 | $17 |
| Zimmer Biomet | 1 | $16 |
| Agiliti Surgical, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,019 in reported general payments places this provider in the 90th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 37 | $10,219 |
| XhanceFluticasone Propionate | 12 | $7,320 |
| Famotidine | 315 | $3,249 |
| Pantoprazole Sodium | 238 | $3,235 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 32 | $2,358 |
| Rabeprazole Sodium | 25 | $1,988 |
| Omeprazole | 91 | $1,371 |
| Ipratropium Bromide | 70 | $1,315 |
| Azelastine Hcl | 12 | $644 |
| Mupirocin | 72 | $393 |
| Doxycycline Monohydrate | 42 | $357 |
| Fluconazole | 12 | $306 |
| Cephalexin | 31 | $278 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $236 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $378 | $7,32012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 103 otolaryngology providers in Iowa.
Other otolaryngology in West Des Moines
- Simon WrightWest Des Moines$21K
- Douglas HoisingtonWest Des Moines$8K
- Arun GuptaWest Des Moines$3K
- Eytan YoungWest Des Moines$2K
- Stephen GriffithWest Des Moines$2K
- Joseph BertrocheWest Des Moines$2K
- Danielle LiudahlWest Des Moines$2K
- Richard RinehartWest Des Moines$954
- Maher YounesWest Des Moines$749
- Douglas SchulteWest Des Moines$587
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.